A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

NCT01674829 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Dry Age Related Macular Degeneration

Interventions

BIOLOGICAL: MA09-hRPE

Sponsor

CHABiotech CO., Ltd